WEBULL
WebtradeDownload

NewMed Energy (TASE:NWMD) Schedules Bond Call, Is The Modest Discount Enough?

Simply Wall St · 1d ago

NewMed Energy bond call puts capital structure in focus

NewMed Energy, Limited Partnership (TASE:NWMD) has called a special meeting for 1 September 2026 to discuss a possible bond offering, putting its funding mix and future financing costs on investors’ radar.

The special call comes as NewMed Energy Limited Partnership trades at ₪17.09, with short term share price momentum modest after a small gain over the past week and a 90 day share price return of 6.15%, while the 5 year total shareholder return above 4x highlights how long term investors have been rewarded and may now reassess risk and funding costs in light of a potential bond issue.

Scan other energy stocks with resilient funding profiles and compare NewMed Energy - Limited Partnership's bond plans against a curated list of solid balance sheet and fundamentals (438 results).

Short term holders in NewMed Energy, Limited Partnership have seen only a modest lift while the long term track record is much stronger. The real issue now is whether today’s bond overhang makes sense as an entry point or a reason to wait.

Most Popular Narrative: 4.5% Undervalued

On the most followed narrative, NewMed Energy - Limited Partnership screens as slightly undervalued, with a fair value of ₪17.9 against the latest close at ₪17.09. This puts the upcoming bond discussion into a valuation context rather than just a funding headline.

Heavy capital commitments to Leviathan phase two, Aphrodite and multiple midstream projects cluster large spending into the next few years. This can pressure free cash flow and limit flexibility if gas demand or realized prices soften, with potential knock on effects for earnings.

Read the complete narrative.

There is a detailed earnings roadmap sitting behind that modest discount. It hinges on sustained revenue expansion, higher profit margins and a different profit multiple than the market is applying today. The fair value assessment is based on those moving parts aligning over time.

Result: Fair Value of ₪17.9 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, the current narrative around NewMed Energy also hinges on risk factors, such as geopolitical disruptions and Brent linked contracts, that could weaken cash flows if conditions turn.

Find out about the key risks to this NewMed Energy - Limited Partnership narrative.

Another View on NewMed Energy valuation

While the narrative highlights NewMed Energy - Limited Partnership as modestly undervalued against a ₪17.9 fair value, the P/E picture sends a different signal. At 24.4x earnings versus 12.2x for the Asian Oil and Gas industry and 18.1x for peers, the stock screens as expensive, which raises the question of how much margin for error is really built in.

See what the numbers say about this price — find out in our valuation breakdown.

TASE:NWMD P/E Ratio as at Sep 2026
TASE:NWMD P/E Ratio as at Sep 2026

Next Steps

If this mix of cautious and optimistic signals around NewMed Energy leaves you undecided, act quickly to review the data and refine your own stance by weighing the 2 key rewards and 3 important warning signs.

Looking for more investment ideas beyond NewMed Energy?

If you are still unsure about NewMed Energy, widen your opportunity set with other stocks that match your risk, income and value preferences using targeted screeners.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.